Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Long-Term Deferred Tax (2020 - 2022)

IceCure Medical has reported Long-Term Deferred Tax over the past 3 years, most recently at $17.3 million for Q4 2022.

  • For Q4 2022, Long-Term Deferred Tax rose 21.84% year-over-year to $17.3 million; the TTM value through Dec 2022 reached $17.3 million, up 21.84%, while the annual FY2022 figure was $17.3 million, 21.84% up from the prior year.
  • Long-Term Deferred Tax was $17.3 million for Q4 2022 at IceCure Medical, up from $14.2 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $17.3 million in Q4 2022 and bottomed at $12.0 million in Q4 2020.
  • The 3-year median for Long-Term Deferred Tax is $14.2 million (2021), against an average of $14.5 million.
  • Year-over-year, Long-Term Deferred Tax rose 17.94% in 2021 and then grew 21.84% in 2022.
  • Over 3 years, Long-Term Deferred Tax stood at $12.0 million in 2020, then increased by 17.94% to $14.2 million in 2021, then increased by 21.84% to $17.3 million in 2022.
  • The last three reported values for Long-Term Deferred Tax were $17.3 million (Q4 2022), $14.2 million (Q4 2021), and $12.0 million (Q4 2020) per Business Quant data.